GovCIO Named Top 100 Companies for Remote Work in 2024
Forbes Magazine published the list compiled by FlexJobs, a jobs site for remote and hybrid work. It ranked 60,000 companies based on the number of remote jobs posted in 2023. GovCIO ranked 90 on the top 100 list, joined by other technology companies such as Twilio, Lumen Technologies, and Hub Spot.
The FlexJobs report saw an 11% increase in the number of remote job listings in 2023 over 2022, with sales, computer, IT, accounting and finance, healthcare, and customer service all seeing growth.
"We're thrilled to be named to FlexJobs' 11th annual list of the Top 100 Companies to Watch for Remote Jobs in 2024," said
"At GovCIO, we take pride in fostering a culture that empowers our employees to thrive in various work settings, including remote opportunities," said
Visit GovCIO Careers to see why we're recognized as one of the best companies for virtual work and view our current remote positions.
About GovCIO
GovCIO is a rapidly growing provider of advanced technology solutions and digital services for the federal government. Combining our extensive federal experience with the latest innovations in IT and disruptive approaches, our experts develop comprehensive solutions to meet the most pressing demands of today's government agencies. From the
GovCIO is transforming government IT, empowering our federal customers to meet the challenges of today while building the government of tomorrow.
Let us show you what we can do. Visit www.govcio.com for more information.
Media Contact
Emyly Hall
Sr. Communications & Marketing Specialist
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/govcio-named-top-100-companies-for-remote-work-in-2024-302062683.html
SOURCE GovCIO
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EVE AIR MOBILITY ACHIEVES FIRST TRANSITION FLIGHT MILESTONE, ADVANCING EVTOL PROGRAM TOWARD WING-BORNE FLIGHT
- Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine
- Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share